Globus Medical, Inc. Class A (GMED)
NYSE · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $10.63B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,344,086
- 52-week high
- —
- 52-week low
- —
- Open
- $76.87
- Day high
- $77.46
- Day low
- $75.68
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $2.94B | $537.87M | $3.92 |
| 2024 | $2.52B | $102.98M | $0.75 |
| 2023 | $1.57B | $122.87M | $1.07 |
| 2022 | $1.02B | $190.17M | $1.85 |
| 2021 | $958.1M | $149.19M | $1.44 |
About Globus Medical, Inc. Class A
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
- CEO
- Keith W. Pfeil
- Employees
- 5,300
- Country
- US
- IPO date
- Aug 3, 2012
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Globus Medical, Inc. Class A's stock price today?
- GMED is trading at $76.01 as of Jul 20, 2026.
- What is Globus Medical, Inc. Class A's market cap?
- Globus Medical, Inc. Class A (GMED) has a market capitalization of $10.63B.
- Does Globus Medical, Inc. Class A pay a dividend?
- Globus Medical, Inc. Class A did not pay a dividend in its most recent reported fiscal year.
- What sector is Globus Medical, Inc. Class A in?
- Globus Medical, Inc. Class A operates in the Healthcare sector.